Surgical antibiotic prophylaxis in children: adherence to indication, choice of agent, timing, and duration

Marta Ciofi degli Atti1, Stefania Spila Alegiani, Roberto Raschetti

  • 1Clinical Epidemiology Unit, Medical Direction, Bambino Gesù Children's Hospital, Rome, Italy, marta.ciofidegliatti@opbg.net.

Insights

Surgical antibiotic prophylaxis (SAP) in children is often not administered when indicated and rarely appropriate. Quality improvement is needed to ensure correct antibiotic use in pediatric surgery.

Area of Science:

  • Pediatric Surgery
  • Infectious Disease Prevention
  • Clinical Pharmacy

Background:

  • Surgical antibiotic prophylaxis (SAP) in pediatric populations is not well-defined.
  • Elective surgical procedures in children require standardized antibiotic protocols.

Purpose of the Study:

  • To investigate the current practices of surgical antibiotic prophylaxis in children undergoing elective surgery.
  • To assess the adherence to and appropriateness of SAP in pediatric patients.

Main Methods:

  • Prospective study of elective pediatric surgeries across three Italian tertiary-care hospitals.
  • Data collected on antibiotic administration, timing, choice, and duration relative to international guidelines.
  • Multivariable logistic regression used to identify predictors of SAP adherence.

Main Results:

  • SAP was administered in 81% of procedures where indicated and 18% where not indicated.
  • Overall appropriateness of SAP (choice, timing, duration) was only 8% when indicated.
  • Procedure type and hospital were significant factors influencing SAP administration.

Conclusions:

  • Low rates of indicated SAP use and poor appropriateness highlight significant concerns in pediatric surgical care.
  • Urgent quality improvement initiatives are necessary to implement evidence-based SAP guidelines in children.
  • Hospital-level evaluation of interventions is crucial to improve SAP practices.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
62.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
155
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
536
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
60
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
251